ARS Pharmaceuticals Inc. (SPRY)
NASDAQ: SPRY
· Real-Time Price · USD
14.53
0.06 (0.41%)
At close: Aug 15, 2025, 3:59 PM
14.65
0.83%
After-hours: Aug 15, 2025, 07:32 PM EDT
ARS Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 51.54M | 39.86M | 50.82M | 39.66M | 36.63M | 56.01M | 70.97M | 60.53M | 119.02M | 87.86M | 210.52M | 37.32M | 44.59M | 233.99M | 60.06M | 300.66M | 359.69M | 374.2M |
Short-Term Investments | 188.59M | 235.86M | 263.2M | 164.97M | 182.12M | 167.63M | 157.39M | 181.37M | 133.19M | 176.69M | 63.86M | n/a | 39.28M | 19.86M | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 24.22M | 44.22M | 65.03M | 40.29M | 350K | 350K |
Other Long-Term Assets | 16.43M | 14.82M | 8.11M | n/a | n/a | n/a | 21K | 2.48M | 2.64M | 2.86M | 2.96M | 22K | -24.2M | n/a | -65.01M | n/a | n/a | n/a |
Receivables | 26.08M | 10.27M | 9.16M | 1.24M | 542K | 618K | 795K | 814K | 962K | 522K | 1.01M | n/a | 35K | n/a | 1K | n/a | n/a | n/a |
Inventory | 8.74M | 7.27M | 5.21M | 715K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 2.03M | 963K | 1.23M | 922K | 497K | 605K | n/a | n/a | n/a | n/a | n/a | 1.18M | n/a | 7.49M | n/a | 4.7M | 3.34M | 4.14M |
Total Current Assets | 281.44M | 303.86M | 334.3M | 208.79M | 220.74M | 226.01M | 231.56M | 244.47M | 255.03M | 267.35M | 277.7M | 39.09M | 45.39M | 261.33M | 60.73M | 305.36M | 363.03M | 378.35M |
Property-Plant & Equipment | 2.64M | 1.15M | 1.07M | 935K | 782K | 814K | 824K | 917K | 943K | 982K | 774K | 615K | 638K | 6.91M | 693K | 6.92M | 3.6M | 3.5M |
Goodwill & Intangibles | 12.97M | 7.49M | 7.68M | 7.88M | 446K | 528K | 617K | 690K | 138K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 32.04M | 23.46M | 16.86M | 8.81M | 1.23M | 1.34M | 1.46M | 4.09M | 3.72M | 3.84M | 3.73M | 637K | 661K | 51.14M | 716K | 47.21M | 3.95M | 3.85M |
Total Assets | 313.47M | 327.32M | 351.15M | 217.6M | 221.97M | 227.58M | 233.19M | 248.56M | 258.75M | 271.19M | 281.44M | 39.73M | 46.05M | 312.47M | 61.45M | 352.56M | 366.98M | 382.2M |
Account Payables | 15.56M | 4.09M | 9.87M | 8.28M | 3.27M | 839K | 759K | 2.97M | 1.5M | 2.58M | 1.66M | 126K | 1.94M | 2.63M | 1.79M | 1.72M | 1.8M | 4.37M |
Deferred Revenue | 746K | 540K | 557K | n/a | n/a | 47K | 4K | n/a | -9.65M | 10K | 283K | n/a | 344K | n/a | 1.46M | n/a | n/a | n/a |
Short-Term Debt | 589K | n/a | n/a | 102K | 160K | 217K | 237K | 235K | 233K | 232K | n/a | 3.52M | 3.5M | 1.12M | 3.48M | 1.09M | 958K | 1.42M |
Other Current Liabilities | 24.4M | 4.73M | 2.29M | 2.48M | 64K | -49K | 839K | 918K | 6.24M | 5.79M | 1.46M | 3.18M | 693K | 11.05M | 660K | 12.54M | 12.79M | 5.8M |
Total Current Liabilities | 45.6M | 27.62M | 23.44M | 16.62M | 6.72M | 3.71M | 2.39M | 11.18M | 10.05M | 9.84M | 5.44M | 8.33M | 7.46M | 14.81M | 8.19M | 15.35M | 15.55M | 11.6M |
Long-Term Debt | 1.07M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.28M | 3.17M | n/a | 4.93M | n/a | n/a | n/a |
Other Long-Term Liabilities | 73.38M | 69.38M | 69.38M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.85M | 2.93M | 76.12M | n/a | 76.12M | n/a | n/a | n/a |
Total Long-Term Liabilities | 75.55M | 70.72M | 70.92M | n/a | n/a | n/a | 37K | 92K | 146K | 199K | 3.1M | 5.52M | 82.62M | 4.43M | 84.53M | 5.08M | 1.78M | 2.06M |
Total Liabilities | 121.15M | 98.34M | 94.36M | 16.62M | 6.72M | 3.71M | 2.43M | 11.27M | 10.2M | 10.04M | 8.55M | 13.85M | 90.08M | 19.24M | 92.72M | 20.43M | 17.33M | 13.65M |
Total Debt | 1.66M | 73K | 42K | 102K | 160K | 217K | 274K | 327K | 379K | 431K | 481K | 6.11M | 7.25M | 5.55M | 9.03M | 6.17M | 2.74M | 3.48M |
Common Stock | 10K | 10K | 10K | 10K | 10K | 10K | 10K | 9K | 9K | 9K | 9K | 260K | 260K | 4K | 257K | 4K | 4K | 3K |
Retained Earnings | -202.13M | -157.25M | -123.31M | -173.24M | -154.11M | -141.59M | -131.3M | -124.14M | -109.27M | -91.9M | -76.94M | -62.51M | -55.93M | -210.84M | -42.26M | -162.75M | -140.1M | -115.6M |
Comprehensive Income | -46K | 72K | 220K | 339K | -145K | -124K | 49K | -161K | -180K | 68K | 407K | n/a | -1.55M | -1.25M | -326K | -34K | n/a | n/a |
Shareholders Equity | 192.32M | 228.97M | 256.8M | 200.98M | 215.24M | 223.87M | 230.76M | 237.28M | 248.55M | 261.15M | 272.89M | 25.88M | -44.03M | 293.23M | -31.27M | 332.13M | 349.65M | 368.55M |
Total Investments | 188.59M | 235.86M | 263.2M | 164.97M | 182.12M | 167.63M | 157.39M | 181.37M | 133.19M | 176.69M | 63.86M | n/a | 39.28M | 64.08M | 65.03M | 40.29M | 350K | 350K |